Document Detail

Studies on the use of thyroid hormone and a thyroid hormone analogue in the treatment of congestive heart failure.
MedLine Citation:
PMID:  8333798     Owner:  NLM     Status:  MEDLINE    
In heart failure, cardiac output is insufficient to meet the needs of the body for oxygen delivery. Available data suggest that alterations in thyroid hormone metabolism may contribute to defective myocardial performance. Accordingly, thyroid hormone or a thyroid hormone analogue that improves cardiac performance might be useful in the treatment of heart failure and has been studied. Experimental and theoretical results of these studies are reviewed and indicate that thyroid hormone increases cardiac output by a combination of effects on the heart and peripheral circulation, specifically by increasing myocardial contractile performance and decreasing venous compliance. In the rat postinfarction model of heart failure, treatment with low doses of thyroxine (1.5 micrograms/100 g) for 3 days produced a positive inotropic response, including an increase in rate of change of left ventricular pressure and a decrease in left ventricular end-diastolic pressure. These changes could be attributed to conversion to triiodothyronine, the active intracellular form of thyroid hormone. When treatment with thyroxine was continued at the same or higher doses (3 to 15 micrograms/100 g) for 10 to 12 days, heart rate increased and improvement in left ventricular end-diastolic pressure was not sustained. More favorable results were obtained with 3,5-diiodothyropropionic acid, a cardiotonic thyroid hormone analogue administered at doses of 375 microgram/100 g, given in combination with captopril. Thus, triiodothyronine or a thyroid hormone analogue may be a useful adjunct to other measures in the treatment of heart failure.
E Morkin; G D Pennock; T E Raya; J J Bahl; S Goldman
Related Documents :
2351998 - Frequently repeated fick cardiac output measurements during anesthesia.
21096038 - Estimated venous return surface and cardiac output curve precisely predicts new hemodyn...
1424858 - Effect of nasal continuous positive airway pressure on cardiac output and oxygen delive...
11990938 - Cardiac tamponade in an orthotopic liver recipient with pulmonary hypertension.
8769748 - Evidence that centrally released arginine vasopressin is involved in central pressor ac...
15118178 - Critical closing pressure in subarachnoid hemorrhage: effect of cerebral vasospasm and ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  56     ISSN:  0003-4975     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  1993 Jul 
Date Detail:
Created Date:  1993-08-17     Completed Date:  1993-08-17     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  S54-60     Citation Subset:  AIM; IM    
Department of Cardiology, Tucson Veterans Administration Medical Center, Arizona.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Captopril / therapeutic use
Cardiac Output
Diiodothyronines / therapeutic use*
Heart Failure / drug therapy*,  physiopathology
Propionic Acids / therapeutic use*
Receptors, Thyroid Hormone / metabolism
Triiodothyronine / physiology,  therapeutic use*
Reg. No./Substance:
0/Diiodothyronines; 0/Propionic Acids; 0/Receptors, Thyroid Hormone; 1158-10-7/3,5-diiodothyropropionic acid; 62571-86-2/Captopril; 6893-02-3/Triiodothyronine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prevalence and clinical implications of abnormal thyroid hormone metabolism in advanced heart failur...
Next Document:  Acute effects of triiodothyronine on arterial smooth muscle cells.